Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-06-10
2011-11-22
Pohnert, Steven (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S024300, C435S091200
Reexamination Certificate
active
08062842
ABSTRACT:
Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
REFERENCES:
patent: 4391904 (1983-07-01), Litman et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5283185 (1994-02-01), Epand et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 6562784 (2003-05-01), Thiel et al.
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: A-2000-143699 (2000-05-01), None
patent: 2007528219 (2007-10-01), None
patent: WO 95/05853 (1995-03-01), None
patent: WO 96/29605 (1996-09-01), None
patent: WO 01/04349 (2001-01-01), None
patent: WO 02/05833 (2002-01-01), None
patent: WO 03/090774 (2003-11-01), None
patent: WO 2005/080594 (2005-09-01), None
Benner et al (Trends in Genetics (2001) vol. 17, pp. 414-418).
Kelly et al., “Rapid and Sensitive Method for Detection of Y402, H402,I62, and V62 Variants of Complement Factor H in Human Plasma Samples Using Mass Spectrometry,” Invest Ophthalmol Vis Sci., Apr. 2009; vol. 50, No. 4, pp. 1540-1545.
Hirokawa et al., “Anti-TSI-RNA: Characterization of Novel Antibodies Against Sequence-Specific RNA by Random RNA Selection in Patients with Sjogren's Syndrome,” J. Rheumatol, 2002, vol. 29, pp. 931-937.
Meyer et al., “MALDI-TOF MS Genotyping of Polymorphisms Related to 1-Carbon Metabolism Using Common and Mass-Modified Terminators,” Clinical Chemistry, 2009, vol. 55, No. 1, pp. 139-149.
Lanzrein A-S et al. (1998), Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease,NeuroReport9:1491-1495.
Hans O et al. (1995), Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein,The Journal of Immunology155:3013-3020.
Emahazion T et al. (2001), SNP association studies in Alzheimer's disease highlight problems for complex disease analysis,Trends in Genetics17:407-413.
Scott WK et al. (2003), Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22,Journal of Human Genetics73:1041-1051.
Hibberd ML et al. (1999), Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease,The Lancet252:1049-1053.
Tang M-X et al. (1998), TheAPOE-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics,JAMA279:751-755.
Bernig T et al. (2004), Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection,Genes and Immunity5:461-476.
Tang Y-W et al. (2000), Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret's meningitis,Clinical Infectious Diseases30:176-178.
Alafuzoff I., Iqbal K., Friden H., Adolfsson R., Winblad B. (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. (Berl) 74: 209-225.
Alloul K., Sauriol L., Kennedy W., Laurier C., Tessier G., Novosel S. et al. (1998) Alzheimer's disease: a review of the disease, its epidemiology and economic impact. Arch. Gerontol. Geriatr. 27: 189-221.
Armstrong M., Daly A.K., Cholerton S., Bateman D.N., Idle J.R. (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339: 1017-1017.
Artiga M.J., Bullido M.J., Sastre., Recuero M., Garcia M.A., Aldudo J., Vazquez J., Valdivieso F. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 421: 105-108.
Benner et al., Evolution, language and analogy in functional genomics, Trends in Genet., vol. 17 (2001), pp. 414-418.
Boldt A.B., Petz-Erler M.L. (2002) A new strategy for mannose-binding lectin gene haplotyping. Hum. Mutat. 19: 296-306.
Brayden D.J., Templeton L., McClean S., Barbour R., Huang J., Nguyen M., Ahem D., Motter R., Johnson-Wood K., Vasquez N., Schenk D., Seubert P. (2001) Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered βamyloid in mice. Vaccine 19: 4185-4193.
Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., Frebourg T. (1999) Earlyonset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65: 664-670.
Celis J.E., Gromov P., Ostergaard M., Madsen P., Honore B., Dejgaard K., Olsen E., Vorum H., Kristensen D.B., Gromova I., Haunso A., Van Damme J., Puype M., Vandekerckhove J., Rasmussen H.H. (1996).
Human 2-D Page databases for proteome analysis in health and disease: http://biobase.dk/cgi-bin/celis. FEBS Lett. 398: 129-134.
Cevc G., Gebauer D., Stieber J., Schatzlein A., Blume G. (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368: 201-215.
Christiansen O.B., Kilpatrick D.C., Souter V., Varming K., Thiel S., Jensenius J.C. (1999) Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand J Imrnunol 49: 193-196.
Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
Costa P., Checkoway H., Levy D., Smith-Weller T., Franklin G.M., Swanson P.D., Costa L.G. (1997) Association of a polymorphism in intron 13 of the monoamine oxidase Bgene with Parkinson disease. Am. J. Med. Genet. 74:154-156.
Croake J.W., Pursley M., Hardin J.G., Michalski J.P. (1998) Systemic lupus erythromatosus and dementia. Psychol. Rep. 83; 1038.
Davidsson PI, Westman A., Puchades M., Nilsson C.L., Blennow K. (1999) Characterization of Proteins from Human Cerebrospinal Fluid by a Combination of Preparative Two-Dimensional Liquid-Phase Electrophoresis and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, Anal. Chem. 71: 642-647.
Delacourte A., David J.P., Seargeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. (1999) The biochemical pathway of neurofribillary degeneration in aging and Alzheimer's disease. Neurology 52: 1158-1165.
den Dunnen J.T., Antonarakis S.E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum. Mutat. 15: 7-12.
Feinglass E.J., Arnett F.C., Dorsch C.A., Zizic T.M., Stevens M.B. (1989) Neuropsychiatric manifestations of systemic lupus erythromatosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 68: 1034.
Finckh U., Muller-Thomsen T., Mann U., Eggers C., Marksteiner J., Meins W., Binetti G., Alberici A., Hock C., Nitsch R.M., Gal A. (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am. J. Hum. Genet. 66: 110-117.
Garred P., Pressler T., Lanng S., Madsen H.O., Moser C., Laursen 1., Balstrup F., Koch C., Koch C. (2002) Mannose-binding lectin (MBL) therapy in an MBLdeficient patient with severe cystic fibrosis lung disease. Pediatr. Pulmonol. 33: 201207.
Garred P., Larsen F., Madsen H.O., Koch C. (2003) deficiency—revisited. Review. Mol. Immunol. 40: 73-84 Mannose-binding lectin.
Glenn G.M., Rao M., Matyas G.R., Alving C.R. (1998) Skin immunization made possible by cholera toxin. Nature 391: 851.
Gut I.G. (2001) Automation in genotyping of single nucleotide polymorphisms. Hum. Mutat. 17: 475-492.
Hanly J.G., Liang M.H. (1997) Cognitive disorders in systemic lupus erythematosus. Epidemiologic
Nuytinck Lieve
Vanmechelen Eugeen
Abbott Healthcare Products B.V.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Pohnert Steven
LandOfFree
Method for determining the risk of developing a neurological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the risk of developing a neurological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the risk of developing a neurological... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4256276